News Releases

2021-02/07
Interim Analysis Results of the Phase I clinical trial of UBIA’s COVID-19 vaccine UB-612
1
2020-12/10
United BioPharma won the “2020 National Talent Development Award''
2
2020-11/11
United BioPharma Received IND Approval from China NMPA for UB-621 Phase 2 Trial in Patients with Recurrent Genital Herpes
3
2020-09/28
COVAXX Initiates Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 in Taiwan
4
2020-08/21
United BioPharma Received IND Approval from China NMPA for a Phase 3 Trial with UB-421 in Patients with Multi-Drug Resistance (MDR) HIV-1 infection
5
2020-08/05
United BioPharma Received Approval from Taiwan FDA for a Phase 1 Trial with UB-421 Subcutaneous Formulation in HIV-1 Infected Patients
6
2020-07/13
Dr. Flossie Wong-Staal, a board member of UBI since 1995, passed away on Wednesday, July 8th, at the age of 73 due to pneumonia
7
2020-05/19
Minister of Health and Welfare led the delegation to visit United BioPharma for the COVID-19 vaccine development program
8
2020-04/27
United BioPharma Received Approval from TFDA for a Phase 3 Trial with UB-421 in Patients with Multi-Drug Resistance (MDR) HIV-1 infection
9
2021-02/07
Interim Analysis Results of the Phase I clinical trial of UBIA’s COVID-19 vaccine UB-612
1
2020-12/10
United BioPharma won the “2020 National Talent Development Award''
2
2020-11/11
United BioPharma Received IND Approval from China NMPA for UB-621 Phase 2 Trial in Patients with Recurrent Genital Herpes
3
2020-09/28
COVAXX Initiates Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 in Taiwan
4
2020-08/21
United BioPharma Received IND Approval from China NMPA for a Phase 3 Trial with UB-421 in Patients with Multi-Drug Resistance (MDR) HIV-1 infection
5
2020-08/05
United BioPharma Received Approval from Taiwan FDA for a Phase 1 Trial with UB-421 Subcutaneous Formulation in HIV-1 Infected Patients
6
2020-07/13
Dr. Flossie Wong-Staal, a board member of UBI since 1995, passed away on Wednesday, July 8th, at the age of 73 due to pneumonia
7
2020-05/19
Minister of Health and Welfare led the delegation to visit United BioPharma for the COVID-19 vaccine development program
8
2020-04/27
United BioPharma Received Approval from TFDA for a Phase 3 Trial with UB-421 in Patients with Multi-Drug Resistance (MDR) HIV-1 infection
9